Prevalence and modern aspects of the treatment of patients with Barrett’s esophagus

Author:

Tsukanov V. V.1,Vasyutin A. V.1,Butorin N. N.2,Tonkikh Yu. L.1,Peretyatko O. V.1,Pulikov A. S.1

Affiliation:

1. Federal Research Center “Krasnoyarsk Research Center” of the Siberian Branch of the Russian Academy of Sciences, a separate subdivision of Research Institute for Medical Problems in the North (NII MPS)

2. Remishevskaya Khakas Republican Hospital

Abstract

The article analyzes the prevalence and principles in treatment of Barrett’s esophagus. The prevalence of Barrett’s esophagus varies widely from region to region of the world and has ethnic differences. The use of endoscopic methods and the histological examination of the biopsies of esophageal mucosa are of utmost importance in the diagnosis of this pathology. The prevention of esophageal cancer is the main task in managing patients with Barrett’s esophagus. The length of the Barrett’s esophagus segment, the presence and extent of dysplasia is of the greatest importance to select tactics for managing patients. Endoscopic methods are widely used for the eradication of metaplasia sites, among which the radiofrequency ablation is the most effective one. Prolonged treatment with proton pump inhibitors is safe and reduces the risk of transformation of Barrett’s esophagus into adenocarcinoma of the esophagus. There is evidence that small doses of aspirin, nonsteroidal anti-inflammatory drugs, statins and ursodeoxycholic acid have the preventive effect on the development of esophageal cancer. However, the possibilities of using these drugs for this purpose are still limited. Anti-reflux surgery still holds relevance, but at the same time, it has no advantages over the drug therapy for the prevention of esophageal cancer.

Publisher

Remedium, Ltd.

Subject

General Medicine

Reference28 articles.

1. Shaheen NJ, Falk GW, Iyer PG, Gerson LB. ACG Clinical Guideline: Diagnosis and Management of Barrett’s Esophagus. Am J Gastroenterol, 2016, 111(1): 30-50.

2. Fitzgerald RC, di Pietro M, Ragunath K, Ang Y, Kang JY, Watson P et al. British Society of Gastroenterology guidelines on the diagnosis and management of Barrett’s oesophagus. Gut, 2014, 63(1): 7-42.

3. Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol, 2008, 103(3): 788-797.

4. Tsukanov VV, Onuchina EV, Vasyutin AV, Butorin NN, Amelchugova OS. Clinical aspects of gastroesophageal reflux disease in the elderly: the 5-year prospective study results. Terapevtichesky Arkhiv, 2014, 86 (2): 23-26.

5. Tsukanov VV, Amelchugova OS, Kasparov EV, Butorin NN, Vasyutin AV, Tonkikh YuL, Tretyakova OV. The role of Helicobacter pylori eradication in the prevention of gastric cancer. Terapevtichesky Arkhiv, 2014, 86 (8): 124-127.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3